EDGAR Filing Documents for 0000897069-03-000668

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

SEC Accession No. 0000897069-03-000668

Filing Date

2003-06-19

Accepted

2003-06-19 17:23:05

Documents

Period of Report

2002-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 20-F AMENDMENT NO. 1	irm373.txt	20-F/A	291332
	Complete submission text file	0000897069-03-000668.txt		292884

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 514-332-32

NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-12033 | Film No.: 03750704
SIC: 2835 In Vitro & In Vivo Diagnostic Substances